-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Fpyzy27Upn5sWMVtHdd9J4On9WtAppVfQJiCW0voju/miYrtK8u/ZNlQSWgXfuqG /VYZip1PLP0DhZXeyeDA8g== 0000950123-11-012808.txt : 20110211 0000950123-11-012808.hdr.sgml : 20110211 20110211162748 ACCESSION NUMBER: 0000950123-11-012808 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20110211 DATE AS OF CHANGE: 20110211 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA INC CENTRAL INDEX KEY: 0001299130 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 161590339 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-85738 FILM NUMBER: 11599519 BUSINESS ADDRESS: STREET 1: 1380 WILLOW ROAD CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-521-8000 MAIL ADDRESS: STREET 1: 1380 WILLOW ROAD CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: NANOFLUIDICS INC DATE OF NAME CHANGE: 20040729 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: GEN PROBE INC CENTRAL INDEX KEY: 0000820237 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330044608 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 10210 GENETIC CENTER DR. CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584108000 MAIL ADDRESS: STREET 1: 10210 GENETIC CENTER DR CITY: SAN DIEGO STATE: CA ZIP: 92121 SC 13G 1 a58568sc13g.htm SC 13G sc13g

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
(Name of Issuer)
COMMON STOCK
(Title of Class of Securities)
69404D 10 8
(CUSIP Number)
DECEMBER 31, 2010
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     o Rule 13d-1(b)

     o Rule 13d-1(c)

     þ Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 

 

                     
CUSIP No.
  
69404D 10 8 
 13G    
Page 2  
   of   
4 Pages 

 

           
1.   NAMES OF REPORTING PERSONS

GEN-PROBE INCORPORATED
     
     
2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
  (a)   o
  (b)   o
     
3.   SEC USE ONLY
   
   
     
4.   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  DELAWARE
       
  5.   SOLE VOTING POWER
     
NUMBER OF   3,276,540
       
SHARES 6.   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7.   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   3,276,540
       
WITH: 8.   SHARED DISPOSITIVE POWER
     
    0
     
9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  3,276,540
     
10.   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
   
  6.2%
     
12.   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  CO

 

Item 1(a).   Name of Issuer:
     PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Item 1(b).   Address of Issuer’s Principal Executive Offices:
     1380 WILLOW ROAD, MENLO PARK, CA 94025
Item 2(a).   Name of Person Filing:
     GEN-PROBE INCORPORATED
Item 2(b).   Address of Principal Business Office:
     10210 GENETIC CENTER DRIVE, SAN DIEGO, CA 92121
Item 2(c).   Citizenship:
     DELAWARE
Item 2(d).   Title of Class of Securities:
     COMMON STOCK
Item 2(e).   CUSIP Number:
     69404D 10 8
Item 3.   Not applicable. Schedule 13G is being filed pursuant to Rule 13d-1(d).
Item 4.   Ownership
  (a)   Amount Beneficially Owned: 3,276,540
 
  (b)   Percent of Class: 6.2%
 
  (c)   Number of shares as to which the person has:
  (i)   Sole power to vote or to direct the vote: 3,276,540
 
  (ii)   Shared power to vote or to direct the vote: 0
 
  (iii)   Sole power to dispose or to direct the disposition of: 3,276,540
 
  (iv)   Shared power to dispose or to direct the disposition of: 0
Item 5.   Ownership of 5 Percent or Less of a Class
     Not applicable.
Item 6.   Ownership of More than 5 Percent on Behalf of Another Person
     Not applicable.
Item 7.   Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
     Not applicable.
Item 8.   Identification and Classification of Members of the Group
     Not applicable.

 

 

Item 9.   Notice of Dissolution of a Group
     Not applicable.
Item 10.   Certification
     Not applicable.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: February 11, 2011
         
  GEN-PROBE INCORPORATED
 		  
  By:   /s/ R. William Bowen    
    R. William Bowen   
    Senior Vice President, General Counsel and Corporate Secretary   
 

 

-----END PRIVACY-ENHANCED MESSAGE-----